WVE

Wave Life Sciences Ltd. Ordinary Shares

12.95

USD

WVE Earnings Reports

Positive Surprise Ratio

WVE beat 9 of 40 last estimates.

23%

Next Report

Date of Next Report

Mar 02, 2026

Estimate for Q4 25 (Revenue/ EPS)

$17.34M

-$0.27

Implied change from Q3 25 (Revenue/ EPS)

+127.97%

-15.63%

Implied change from Q4 24 (Revenue/ EPS)

-79.29%

-258.82%

Wave Life Sciences Ltd. Ordinary Shares earnings per share and revenue

On Nov 10, 2025, WVE reported earnings of -0.32 USD per share (EPS) for Q3 25, missing the estimate of -0.30 USD, resulting in a -6.21% surprise. Revenue reached 7.61 million, compared to an expected 11.24 million, with a -32.32% difference. The market reacted with a -10.31% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 17 analysts forecast an EPS of -0.27 USD, with revenue projected to reach 17.34 million USD, implying an decrease of -15.63% EPS, and increase of 127.97% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

FAQ

What were Wave Life Sciences Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Wave Life Sciences Ltd. Ordinary Shares reported EPS of -$0.32, missing estimates by -6.21%, and revenue of $7.61M, -32.32% below expectations.

How did the market react to Wave Life Sciences Ltd. Ordinary Shares's Q3 2025 earnings?

The stock price moved down -10.31%, changed from $7.86 before the earnings release to $7.05 the day after.

When is Wave Life Sciences Ltd. Ordinary Shares expected to report next?

The next earning report is scheduled for Mar 02, 2026.

What are the forecasts for Wave Life Sciences Ltd. Ordinary Shares's next earnings report?

Based on 17 analysts, Wave Life Sciences Ltd. Ordinary Shares is expected to report EPS of -$0.27 and revenue of $17.34M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.